Deans' stroke musings: Getting From Care to Cure -Milken Institute 2012 Global Conference

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, May 7, 2012

Getting From Care to Cure -Milken Institute 2012 Global Conference

You can listen to the 67 minute talk but these people are way too high level to be discussing solutions. Put me and ePatient Dave together and we would solution everything.
http://www.milkeninstitute.org/events/gcprogram.taf?function=detail&EvID=3263&eventid=GC12
Improving the efficiency and quality of our health-care delivery system is vital to improving treatment outcomes, and it's just as critical to improving the cure enterprise. An efficient health-care system could free up funding for research and development. And by championing improved technologies such as electronic health records, we can serve the dual purposes of improving existing care programs while supporting the intense data needs of biomedical research. This panel will focus on developing successful models to reduce costs, making better use of data from the health-care system for research purposes, and encouraging biotechnology and pharmaceutical companies to focus on the reimbursement pathway well before the product is at the market's doorstep.